CNP Q2 adj EPS $0.40 vs. est. $0.37; increased 10-year capital investment plan by $1.2B to $66.7B; reiterated full-year 2026 non-GAAP EPS gu
CNP Q2 adj EPS $0.40 vs. est. $0.37; increased 10-year capital investment plan by $1.2B to $66.7B; reiterated full-year 2026 non-GAAP EPS guidance; aid Q2 results were primarily driven by growth and regulatory recovery, contributing $0.10 per share of favorability compared to Q2 2025.
CNP Q2 adj EPS $0.40 vs. est. $0.37; increased 10-year capital investment plan by $1.2B to $66.7B; reiterated full-year 2026 non-GAAP EPS guidance; aid Q2 results were primarily driven by growth and regulatory recovery, contributing $0.10 per share of favorability compared to Q2 2025.